company background image
LSDI logo

Lucy Scientific Discovery NasdaqCM:LSDI Stock Report

Last Price

US$0.89

Market Cap

US$1.5m

7D

-0.9%

1Y

-93.3%

Updated

01 May, 2024

Data

Company Financials

Lucy Scientific Discovery Inc.

NasdaqCM:LSDI Stock Report

Market Cap: US$1.5m

LSDI Stock Overview

Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products.

LSDI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Lucy Scientific Discovery Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lucy Scientific Discovery
Historical stock prices
Current Share PriceUS$0.89
52 Week HighUS$17.00
52 Week LowUS$0.72
Beta0
1 Month Change-33.60%
3 Month Change-62.91%
1 Year Change-93.26%
3 Year Changen/a
5 Year Changen/a
Change since IPO-97.02%

Recent News & Updates

Recent updates

Shareholder Returns

LSDIUS PharmaceuticalsUS Market
7D-0.9%3.0%-0.7%
1Y-93.3%12.5%22.8%

Return vs Industry: LSDI underperformed the US Pharmaceuticals industry which returned 11.6% over the past year.

Return vs Market: LSDI underperformed the US Market which returned 22.3% over the past year.

Price Volatility

Is LSDI's price volatile compared to industry and market?
LSDI volatility
LSDI Average Weekly Movement16.0%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement6.1%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.0%

Stable Share Price: LSDI's share price has been volatile over the past 3 months.

Volatility Over Time: LSDI's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20172Richard Nanulawww.lucyscientific.com

Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications.

Lucy Scientific Discovery Inc. Fundamentals Summary

How do Lucy Scientific Discovery's earnings and revenue compare to its market cap?
LSDI fundamental statistics
Market capUS$1.47m
Earnings (TTM)-US$10.23m
Revenue (TTM)US$16.73k

93.9x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LSDI income statement (TTM)
RevenueUS$16.73k
Cost of RevenueUS$8.37k
Gross ProfitUS$8.36k
Other ExpensesUS$10.24m
Earnings-US$10.23m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-5.80
Gross Margin49.99%
Net Profit Margin-61,141.13%
Debt/Equity Ratio85.7%

How did LSDI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.